The AspiriN To Inhibit SEPSIS (ANTISEPSIS) trial; an ASPREE substudy to measure the benefit of low dose aspirin in the prevention of severe sepsis.

Eisen, Damon P. (Primary Chief Investigator (PCI))
Leder, Karin (Chief Investigator (CI))
Mcbryde, Emma S. (Chief Investigator (CI))
Pilcher, David (Chief Investigator (CI))
Wolfe, Rory (Chief Investigator (CI))
Woods, Robyn (Chief Investigator (CI))

Epidemiology and Preventive Medicine Alfred Hospital

Project: Research

Status	Finished
Effective start/end date	1/01/13 → 31/12/18

Funding

National Health and Medical Research Council (NHMRC) (Australia): A$391,879.55

1 Article

Effect of aspirin on deaths associated with sepsis in healthy older people (ANTISEPSIS): a randomised, double-blind, placebo-controlled primary prevention trial
Eisen, D. P., Leder, K., Woods, R. L., Lockery, J. E., McGuinness, S. L., Wolfe, R., Pilcher, D., Moore, E. M., Shastry, A., Nelson, M. R., Reid, C. M., McNeil, J. J. & McBryde, E. S., Feb 2021, In: The Lancet Respiratory Medicine. 9, 2, p. 186-195 10 p.
Research output: Contribution to journal › Article › Research › peer-review

28 Citations (Scopus)